Laszlo Hegedüs

1.2k total citations
16 papers, 723 citations indexed

About

Laszlo Hegedüs is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Laszlo Hegedüs has authored 16 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Surgery and 3 papers in Genetics. Recurrent topics in Laszlo Hegedüs's work include Thyroid Disorders and Treatments (10 papers), Thyroid Cancer Diagnosis and Treatment (5 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). Laszlo Hegedüs is often cited by papers focused on Thyroid Disorders and Treatments (10 papers), Thyroid Cancer Diagnosis and Treatment (5 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). Laszlo Hegedüs collaborates with scholars based in Denmark, Netherlands and United Kingdom. Laszlo Hegedüs's co-authors include Finn Noe Bennedbæk, Steen Joop Bonnema, Claus Henrik Nielsen, Daniel El Fassi, Hans Carl Hasselbalch, Lars Bastholt, Bo Mølholm Hansen, Jens M. Hansen, N. Knudsen and P. B. Andersen and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Endocrinology and Human Molecular Genetics.

In The Last Decade

Laszlo Hegedüs

14 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laszlo Hegedüs Denmark 11 573 276 140 121 57 16 723
Yoshihito Hara Japan 11 345 0.6× 205 0.7× 75 0.5× 79 0.7× 81 1.4× 29 600
Elisa Guarino Italy 14 277 0.5× 213 0.8× 46 0.3× 45 0.4× 67 1.2× 18 620
Semra Aytürk Türkiye 11 355 0.6× 113 0.4× 31 0.2× 39 0.3× 41 0.7× 29 475
Ved Bhushan Arya United Kingdom 17 695 1.2× 431 1.6× 178 1.3× 37 0.3× 18 0.3× 56 945
Gwen Wark United Kingdom 12 333 0.6× 111 0.4× 106 0.8× 16 0.1× 34 0.6× 20 537
W M McConahey United States 10 967 1.7× 530 1.9× 223 1.6× 129 1.1× 27 0.5× 13 1.1k
Augusto Taccaliti Italy 14 254 0.4× 151 0.5× 51 0.4× 31 0.3× 16 0.3× 29 422
H Jarosz United States 14 359 0.6× 298 1.1× 62 0.4× 36 0.3× 13 0.2× 21 577
L Baldet France 11 592 1.0× 214 0.8× 93 0.7× 35 0.3× 45 0.8× 38 702
Ferenc Győry Hungary 13 159 0.3× 89 0.3× 26 0.2× 58 0.5× 35 0.6× 48 449

Countries citing papers authored by Laszlo Hegedüs

Since Specialization
Citations

This map shows the geographic impact of Laszlo Hegedüs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laszlo Hegedüs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laszlo Hegedüs more than expected).

Fields of papers citing papers by Laszlo Hegedüs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laszlo Hegedüs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laszlo Hegedüs. The network helps show where Laszlo Hegedüs may publish in the future.

Co-authorship network of co-authors of Laszlo Hegedüs

This figure shows the co-authorship network connecting the top 25 collaborators of Laszlo Hegedüs. A scholar is included among the top collaborators of Laszlo Hegedüs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laszlo Hegedüs. Laszlo Hegedüs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Vilsbøll, Tina, Michael Stellfeld, Vanita R. Aroda, et al.. (2025). Assessment of thyroid cancer risk associated with glucagon‐like peptide 1 receptor agonist use. Diabetes Obesity and Metabolism. 28(2). 1499–1507.
2.
Melo, Miguel, Roberto Attanasio, Laszlo Hegedüs, et al.. (2022). Use of Thyroid Hormones in Hypothyroid and Euthyroid Patients: A THESIS Questionnaire Survey of Portuguese Endocrinologists. University of Southern Denmark Research Portal (University of Southern Denmark). 2 indexed citations
3.
Hegedüs, Laszlo. (2018). Does therapy for thyroid dysfunction decrease mortality?. Endocrine Abstracts.
4.
Fast, Søren, Laszlo Hegedüs, Peter Grupe, et al.. (2010). Recombinant Human Thyrotropin-Stimulated Radioiodine Therapy of Nodular Goiter Allows Major Reduction of the Radiation Burden with Retained Efficacy. The Journal of Clinical Endocrinology & Metabolism. 95(8). 3719–3725. 28 indexed citations
5.
Brand, Stephan, Jeffrey C. Barrett, Matthew J. Simmonds, et al.. (2009). Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves' disease. Human Molecular Genetics. 18(9). 1704–1713. 95 indexed citations
6.
Brix, Thomas Heiberg, Pia Skov Hansen, Kirsten Ohm Kyvik, & Laszlo Hegedüs. (2009). Aggregation of Thyroid Autoantibodies in Twins from Opposite-Sex Pairs Suggests that Microchimerism May Play a Role in the Early Stages of Thyroid Autoimmunity. The Journal of Clinical Endocrinology & Metabolism. 94(11). 4439–4443. 26 indexed citations
7.
Deure, Wendy M. van der, Pia Skov Hansen, Robin P. Peeters, et al.. (2008). Thyroid Hormone Transport and Metabolism by Organic Anion Transporter 1C1 and Consequences of Genetic Variation. Endocrinology. 149(10). 5307–5314. 59 indexed citations
8.
Banga, J. Paul, Claus Henrik Nielsen, Jacqueline A. Gilbert, Daniel El Fassi, & Laszlo Hegedüs. (2008). Application of New Therapies in Graves' Disease and Thyroid-Associated Ophthalmopathy: Animal Models and Translation to Human Clinical Trials. Thyroid. 18(9). 973–981. 17 indexed citations
9.
Bonnema, Steen Joop, Viveque Egsgaard Nielsen, Peter Grupe, et al.. (2008). Recombinant Human Thyrotropin-Stimulated Radioiodine Therapy of Large Nodular Goiters Facilitates Tracheal Decompression and Improves Inspiration. The Journal of Clinical Endocrinology & Metabolism. 93(10). 3981–3984. 34 indexed citations
10.
Fassi, Daniel El, Claus Henrik Nielsen, Steen Joop Bonnema, Hans Carl Hasselbalch, & Laszlo Hegedüs. (2007). B Lymphocyte Depletion with the Monoclonal Antibody Rituximab in Graves’ Disease: A Controlled Pilot Study. The Journal of Clinical Endocrinology & Metabolism. 92(5). 1769–1772. 113 indexed citations
11.
Bonnema, Steen Joop, et al.. (2005). Glucocorticoids do not influence the effect of radioiodine therapy in Graves’ disease. European Journal of Endocrinology. 153(1). 15–21. 32 indexed citations
12.
Hansen, Pia Skov & Laszlo Hegedüs. (2005). Importance of genetics for interindividual thyroid function variation in healthy subjects.. University of Southern Denmark Research Portal (University of Southern Denmark). 1 indexed citations
13.
Bennedbæk, Finn Noe & Laszlo Hegedüs. (2000). Management of the Solitary Thyroid Nodule: Results of a North American Survey1. The Journal of Clinical Endocrinology & Metabolism. 85(7). 2493–2498. 131 indexed citations
14.
Bonnema, Steen Joop, Henrik Bertelsen, Jesper Mortensen, et al.. (1999). The Feasibility of High Dose Iodine 131 Treatment as an Alternative to Surgery in Patients with a Very Large Goiter: Effect on Thyroid Function and Size and Pulmonary Function*. The Journal of Clinical Endocrinology & Metabolism. 84(10). 3636–3641. 99 indexed citations
15.
Hegedüs, Laszlo, Bo Mølholm Hansen, N. Knudsen, & Jens M. Hansen. (1988). Reduction of size of thyroid with radioactive iodine in multinodular non-toxic goitre.. BMJ. 297(6649). 661–662. 82 indexed citations
16.
Hegedüs, Laszlo, et al.. (1987). Thyroid size and goitre frequency in hyperthyroidism.. PubMed. 34(2). 121–3. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshihito Hara Breakdown of academic impact, for papers by Elisa Guarino Breakdown of academic impact, for papers by Semra Aytürk Breakdown of academic impact, for papers by Ved Bhushan Arya Breakdown of academic impact, for papers by Gwen Wark Breakdown of academic impact, for papers by W M McConahey Breakdown of academic impact, for papers by Augusto Taccaliti Breakdown of academic impact, for papers by H Jarosz Breakdown of academic impact, for papers by L Baldet Breakdown of academic impact, for papers by Ferenc Győry
Rankless by CCL
2026